tradingkey.logo

AxoGen Inc

AXGN

17.260USD

+0.440+2.62%
Cierre 09/18, 16:00ETCotizaciones retrasadas 15 min
789.91MCap. mercado
PérdidaP/E TTM
Más Datos de AxoGen Inc Compañía
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Información de la empresa
Símbolo de cotizaciónAXGN
Nombre de la empresaAxoGen Inc
Fecha de salida a bolsaDec 17, 1986
Director ejecutivoMr. Michael Donald (Mike) Dale
Número de empleados451
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 17
Dirección13631 Progress Blvd.
CiudadALACHUA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32615
Teléfono13864626817
Sitio Webhttps://www.axogeninc.com/
Símbolo de cotizaciónAXGN
Fecha de salida a bolsaDec 17, 1986
Director ejecutivoMr. Michael Donald (Mike) Dale
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Desglose de ingresos
FY2023
FY2022
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
159.01M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
Otro
69.10%
Accionistas
Accionistas
Proporción
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
Otro
69.10%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
36.08%
Investment Advisor
26.43%
Hedge Fund
18.12%
Research Firm
5.98%
Individual Investor
4.69%
Bank and Trust
0.34%
Pension Fund
0.30%
Sovereign Wealth Fund
0.13%
Insurance Company
0.03%
Otro
7.90%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
352
41.91M
91.08%
-2.35M
2025Q1
357
42.08M
92.45%
-1.70M
2024Q4
343
39.00M
87.97%
-5.62M
2024Q3
323
39.49M
90.05%
-1.54M
2024Q2
302
38.53M
87.94%
-4.16M
2024Q1
307
37.61M
87.02%
-4.05M
2023Q4
318
35.68M
82.81%
-5.15M
2023Q3
322
35.50M
82.64%
-5.39M
2023Q2
319
36.28M
84.47%
-3.01M
2023Q1
324
35.99M
84.11%
-3.05M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Light Asset Management, LLC
4.47M
9.82%
-32.58K
-0.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
6.87%
+93.19K
+3.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
5.55%
+103.94K
+4.28%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.59M
3.48%
-105.62K
-6.24%
Mar 31, 2025
Balyasny Asset Management LP
680.19K
1.49%
+380.25K
+126.77%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
1.59M
3.49%
-657.69K
-29.25%
Mar 31, 2025
Soleus Capital Management, L.P.
1.45M
3.18%
-1.51M
-51.08%
Mar 31, 2025
Wasatch Global Investors Inc
774.63K
1.7%
+774.63K
--
Mar 31, 2025
Zaderej (Karen L)
1.14M
2.51%
+71.04K
+6.62%
Mar 21, 2024
State Street Global Advisors (US)
1.01M
2.23%
+49.10K
+5.08%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI